Northern Virginia Community Hospital LLC

Northern Virginia Community Hospital LLC was paid $5.43M by Medicaid between Jan 2018 and Dec 2024, across 101 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.

33Billing provider infoNORTHERN VIRGINIA COMMUNITY HOSPITAL LLC
DULLES, VA 20166

33aNPI1972904738assigned 09/11/2014

33bProvider typeGeneral Acute Care Hospital

28Total paid$5.43M

24GClaims123,577

24DCodes billed101

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Virginia

Rank by total paid#56 of 80

Median peer was paid$14.69M

This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	8,205	$236K
2019	13,896	$396K
2020	12,415	$432K
2021	17,954	$678K
2022	24,270	$1.13M
2023	26,224	$1.36M
2024incomplete	20,613	$1.21M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	33%	9,581	8,386	$1.77M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	27%	7,852	6,634	$1.44M
99282	Emergency department visit for the evaluation and management, low to moderate severity	11%	3,235	2,899	$581K
96361	Intravenous infusion, hydration; each additional hour	5.5%	1,374	1,225	$299K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.3%	1,842	1,539	$288K
74177	Computed tomography, abdomen and pelvis; with contrast material	4.6%	1,259	1,140	$253K
70450	Computed tomography, head or brain; without contrast material	4.0%	1,520	1,303	$218K
G0378	Hospital observation service, per hour	3.0%	1,425	765	$161K
99281	Emergency department visit for the evaluation and management, self-limited or minor	1.3%	339	329	$69K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	245	217	$43K
93975		<1%	359	337	$37K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,576	1,401	$28K

89 more codes

96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	146	$19K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	172	$19K
80053	Comprehensive metabolic panel	<1%	6,181	$18K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	239	$16K
76830	Ultrasound, transvaginal	<1%	157	$15K
80048	Basic metabolic panel (calcium, ionized)	<1%	4,231	$15K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	156	$13K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	69	$13K
71046	Radiologic examination, chest; 2 views	<1%	708	$13K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	5,101	$11K
59025	Fetal non-stress test	<1%	49	$10K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	5,398	$8K
71045	Radiologic examination, chest; single view	<1%	3,797	$8K
85027		<1%	10,468	$7K
71275	Computed tomographic angiography, chest, with contrast material	<1%	36	$7K
70496		<1%	26	$6K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	155	$6K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	81	$5K
84484		<1%	3,843	$4K
80076		<1%	1,544	$3K
86756		<1%	939	$3K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	42	$2K
36415	Collection of venous blood by venipuncture	<1%	1,082	$2K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	102	$2K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	639	$2K
96375	Therapeutic injection; each additional sequential IV push	<1%	2,335	$2K
73564		<1%	47	$2K
87040		<1%	299	$2K
J7030	Infusion, normal saline solution , 1000 cc	<1%	5,269	$2K
85610		<1%	1,965	$1K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	2,817	$1K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	27	$1K
84703		<1%	2,521	$856.12
81003		<1%	1,431	$728.04
81001		<1%	3,071	$705.27
84443	Thyroid stimulating hormone (TSH)	<1%	346	$695.95
83690		<1%	2,734	$691.87
85379		<1%	350	$684.89
83880		<1%	137	$571.30
86900		<1%	726	$550.89
73030		<1%	43	$532.54
86850		<1%	323	$482.25
72125	Computed tomography, cervical spine; without contrast material	<1%	26	$458.84
83735		<1%	1,462	$448.06
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	3,092	$436.73
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	2,296	$383.09
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	3,839	$366.00
73610		<1%	44	$335.48
87086	Culture, bacterial; quantitative colony count, urine	<1%	629	$307.24
73130		<1%	25	$305.76
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	2,936	$296.94
87070		<1%	583	$244.89
73110		<1%	13	$244.02
85730		<1%	806	$239.46
73630		<1%	12	$225.78
86901		<1%	309	$209.38
J7120	Ringers lactate infusion, up to 1000 cc	<1%	1,357	$196.65
74018		<1%	16	$134.62
81025		<1%	355	$113.33
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,416	$112.12
83605		<1%	194	$109.33
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,176	$91.35
82550		<1%	64	$91.16
80061	Lipid panel	<1%	12	$64.35
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	32	$53.11
84439		<1%	14	$51.12
84702		<1%	124	$35.43
J1170	Injection, hydromorphone, up to 4 mg	<1%	507	$22.03
96376		<1%	13	$19.88
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	605	$19.58
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	157	$8.30
J2060	Injection, lorazepam, 2 mg	<1%	37	$4.50
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	126	$3.25
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	147	$1.25
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	40	$1.25
G1003	Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program	0%	14	$0.00
76000		0%	39	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	16	$0.00
S0028	Injection, famotidine, 20 mg	0%	12	$0.00
J3010	Injection, fentanyl citrate, 0.1 mg	0%	29	$0.00
A9270	Non-covered item or service	0%	311	$0.00
J2704	Injection, propofol, 10 mg	0%	17	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	23	$0.00
J3490	Unclassified drugs	0%	128	$0.00
94760		0%	14	$0.00
87807		0%	37	$0.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	0%	37	$0.00
70498		0%	12	$0.00
J2250	Injection, midazolam hydrochloride, per 1 mg	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSAFINA, JULIA (CFO)